Resource List

Recently, Viwit Pharmaceutical Co., Ltd. announced that its independently developed Gadoterate Meglumine Injection (5 mmol/10 mL, 7.5 mmol/15 mL, and 10 mmol/20 mL) has received FDA approval of its Abbreviated New Drug Application (ANDA), officially entering the U.S. market.

Recently, major news emerged in the innovative drug sector: the world’s first semaglutide nasal spray independently developed by Shanghai World Leader Pharmaceutical Co., Ltd.—a Class 2.2 improved new chemical drug—achieved dual clinical regulatory breakthroughs in China and the United States:

We are delighted to share exciting news from our client, Fosun Wanbang (Jiangsu) Pharmaceutical Group Co., Ltd.: sitagliptin and metformin hydrochloride extended-release tablets, supported by Milestone Pharma’s technical expertise, have received tentative approval from the U.S. FDA.

Good news! Through Milestone Pharma’s medical device chemical characterization services, Micro-Tech (Nanjing) Co., Ltd.’s flagship product, the Sterile Repositionable Hemostasis Clipping Device, has successfully obtained an EU CE certificate under the MDR issued by BSI.